Pipeline

Rain intends to build a targeted oncology platform, with the first program, tarloxotinib (Tarlox), holding promise across various indications

Tarlox Development Overview

IndicationDiscoveryPreclinicalPhase 1Phase 2

Tarloxotinib

Undisclosed Indication